CXI Healthcare Technology Group KRX:900120KOSDAQ
씨엑스아이 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days3
Articles tracked10since Sep 11
In Q1 2026, CXI Healthcare Technology Group reported revenue of ₩37m, down 30.7% year on year, and an operating loss of ₩12m. CXI Healthcare Technology Group (씨엑스아이) appeared in 0 Korean news articles and 3 DART filings over the past seven days. Coverage peaked on Oct 18 with 1 article.
CXI Healthcare Technology Group quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q1 2026 | ₩37m | -30.7% | −₩12m margin −33.3% | −₩13m |
| Q4 2025 | ₩37m | -22.6% | −₩19m margin −50.0% | −₩19m |
| Q3 2025 | ₩84m | -12.4% | ₩25m margin 29.6% | ₩24m |
| Q2 2025 derived | ₩99m | -28.7% | ₩39m margin 39.2% | ₩53m |
| Q1 2025 | ₩53m | -24.3% | −₩8m margin −14.3% | −₩8m |
| Q4 2024 | ₩48m | – | −₩13m margin −26.3% | −₩13m |
| Q3 2024 | ₩96m | – | ₩31m margin 32.7% | ₩33m |
| Q2 2024 derived | ₩139m | +10.2% | ₩80m margin 57.4% | ₩114m |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
CXI Healthcare Technology Group top stories 2 weeks, by number of outlets
- 1
Latest CXI Healthcare Technology Group news Korean headlines
-
[공시] 씨엑스아이 매출액또는손익구조30%(대규모법인은15%)이상변동 (자회사의 주요경영사항)
2 more on this story · 1 outlets
- [공시] 씨엑스아이 매출액또는손익구조30%(대규모법인은15%)이상변동스페셜타임스 · Oct 8 20:49
- [공시] 씨엑스아이 매출액또는손익구조30%(대규모법인은15%)이상변동 (자회사의 주요경영사항)스페셜타임스 · Oct 8 20:49